---
layout: post
title: "Certain Plant-Derived Recombinant Human Serum Albumins (“rHSA”) and Products Containing Same Notice of Commission Determination To Review the Final Initial Determination in Its Entirety; Schedule for Filing Written Submissions"
date: 2026-02-05 18:59:28 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-12500
original_published: 2022-06-10 00:00:00 +0000
significance: 8.00
---

# Certain Plant-Derived Recombinant Human Serum Albumins (“rHSA”) and Products Containing Same Notice of Commission Determination To Review the Final Initial Determination in Its Entirety; Schedule for Filing Written Submissions

**Published:** February 05, 2026 18:59 UTC
**Source:** Federal Register
**Original Published:** June 10, 2022 00:00 UTC
**Document Number:** 2022-12500

## Summary

Notice is hereby given that the U.S. International Trade Commission has determined to review the final initial determination ("final ID") issued by the presiding administrative law judge ("ALJ") on April 7, 2022, in its entirety. The Commission requests briefing from the parties on certain issues under review, as indicated in this notice. The Commission also requests briefing from the parties, interested government agencies, and interested persons on the issues of remedy, the public interest, and bonding.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/06/10/2022-12500/certain-plant-derived-recombinant-human-serum-albumins-rhsa-and-products-containing-same-notice-of)
- API: https://www.federalregister.gov/api/v1/documents/2022-12500

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
